Cargando…
Assessment of long-term safety and efficacy of intranasal mesenchymal stem cell treatment for neonatal brain injury in the mouse
BACKGROUND: For clinical translation, we assessed whether intranasal mesenchymal stem cell (MSC) treatment after hypoxia–ischemia (HI) induces neoplasia in the brain or periphery at 14 mo. Furthermore, the long-term effects of MSCs on behavior and lesion size were determined. METHOD: HI was induced...
Autores principales: | Donega, Vanessa, Nijboer, Cora H., van Velthoven, Cindy T. J., Youssef, Sameh A., de Bruin, Alain, van Bel, Frank, Kavelaars, Annemieke, Heijnen, Cobi J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635434/ https://www.ncbi.nlm.nih.gov/pubmed/26270577 http://dx.doi.org/10.1038/pr.2015.145 |
Ejemplares similares
-
Intranasal Mesenchymal Stem Cell Treatment for Neonatal Brain Damage: Long-Term Cognitive and Sensorimotor Improvement
por: Donega, Vanessa, et al.
Publicado: (2013) -
Intranasal Administration of Human MSC for Ischemic Brain Injury in the Mouse: In Vitro and In Vivo Neuroregenerative Functions
por: Donega, Vanessa, et al.
Publicado: (2014) -
The rodent endovascular puncture model of subarachnoid hemorrhage: mechanisms of brain damage and therapeutic strategies
por: Kooijman, Elke, et al.
Publicado: (2014) -
Pharmacological Neuroprotection after Perinatal Hypoxic-Ischemic Brain Injury
por: Fan, Xiyong, et al.
Publicado: (2010) -
Mitochondrial transfer from mesenchymal stem cells to neural stem cells protects against the neurotoxic effects of cisplatin
por: Boukelmoune, Nabila, et al.
Publicado: (2018)